missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18463828

POLR2J2 Antibody (OTI3G4), DyLight 594, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-73520DL594

Product Code. 18463828

  • £595.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

POLR2J2 Monoclonal antibody specifically detects POLR2J2 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

POLR2J2
Monoclonal
DyLight 594
DNA directed RNA polymerase II polypeptide J-related, DNA-directed RNA polymerase II subunit RPB11-b1, HRPB11B, MGC105050, MGC54043, polymerase (RNA) II (DNA directed) polypeptide J2, RNA polymerase II subunit B11-b1, RPB11, RPB11b1DNA-directed RNA polymerase II subunit J2
Full length recombinant protein of human POLR2J2 (NP_116581) produced in HEK293T cells.
0.1 mL
DNA replication Transcription Translation and Splicing
246721
Store at 4°C in the dark.
IgG2a
Western Blot, Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin)
OTI3G4
50mM Sodium Borate
Mouse
Immunogen affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.